Skip to main content

Peter K Honig, M.D., MPH

Equibles does not estimate personal net worth.

Get an email with a short summary when Karyopharm Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get KPTI alerts

About Peter K Honig, M.D., MPH

Peter K Honig, M.D., MPH is recorded as Board Member at Karyopharm Therapeutics Inc. (KPTI) since December 3, 2021. Karyopharm Therapeutics Inc. reported in an 8-K filed December 6, 2021 that Peter K Honig, M.D., MPH was appointed independent director, effective December 3, 2021. Karyopharm Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Karyopharm Therapeutics Inc. includes Richard Paulson (CEO and Board Member), Senior Clinical (CEO), Michael Mano (General Counsel) and 7 others.

“On December 3, 2021, the Board, upon the recommendation of the Nominating, Corporate Governance & Compliance Committee of the Board, elected Peter K Honig, M.D., MPH, as an independent director of the Company to fill a vacancy on the Board.”
Karyopharm Therapeutics Inc. Form 8-K, filed December 6, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Karyopharm Therapeutics Inc.

Recent activity